Skip to main content
Caplight Logo









AdhereTech

AdhereTech

Private
New York City, New YorkHealthcare & Life Scienceshttps://adheretech.com/

Last Round

Growth Equity

Nov 1, 2018

Est. Valuation

$333,000

Total Funding Raised

$2.39M

Company Overview

AdhereTech is a digital health company that provides medication adherence solutions for pharmaceutical companies and healthcare teams through its smart cellular-connected devices and software platform.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Health IoT, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

medication adherencesmart pill bottledigital healthpatient engagementhealth IoTmedication non-adherenceconnected healthpatient support programremote patient monitoringRPMhealthcare analyticstherapy persistencemedication trackingsmart packagingB2B2C healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AdhereTech Comparables

Compare AdhereTech with similar companies based on industry and business-model similarity.

AdhereTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SMRxT
88%
RxCap
84%
PersonalRX
81%

AdhereTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityNov 1, 2018
Series AJul 10, 2014
SeedOct 14, 2013
AcceleratorJul 19, 2012

Key People

Founding team and executive leadership

Jeremy Gilbert

CEO

Executive Team

AdhereTech Investors

Notable investors and investment history

AdhereTech investors
InvestorRounds
Argentum GroupGrowth Equity
StartUp HealthSeed
Blueprint HealthSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Jeremy Gilbert named new chief executive officer.

  • Jan 6, 2025

    Life sciences executive Dean McAlister joins the Board of Directors.

AdhereTech Filings

Explore SEC and related filing metadata, where available.

AdhereTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AdhereTech's valuation, stock price, and market status.

Is AdhereTech a public or private company?

AdhereTech is a private company.

What is the current stock price of AdhereTech?

AdhereTech is a private company with no public stock price. No recent secondary market data is available.

How much is AdhereTech worth (valuation)?

AdhereTech's valuation is estimated at $333.0K based on funding round data.

Can I buy AdhereTech stock?

AdhereTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AdhereTech's last funding round?

AdhereTech's most recent funding round was Growth Equity on July 19, 2012.

Who are the main investors in AdhereTech?

Key investors in AdhereTech include Blueprint Health.

Will AdhereTech IPO soon?

No public IPO plans have been announced for AdhereTech.

How can I track AdhereTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AdhereTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range16
Year Founded2011
Last FundingNov 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?